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Abstract
In 2008 and 2009, acute mortalities occurred in France among Pacific cupped oyster, Crassostrea gigas, spat.
Different hypothesis including the implication of environmental factors, toxic algae and/or pathogens have been
explored. Diagnostic tests indicated that OsHV-1 including a particular genotype, termed OsHV-1 μVar, was
detected in most of samples and especially in moribund oysters with the highlighting of virus particles looking like
herpes viruses by TEM examination. In this study, an experimental protocol to reproduce OsHV-1 infection in
laboratory conditions was developed. This protocol was based on the intramuscular injection of filtered (0.22 μm)
tissue homogenates prepared from naturally OsHV-1 infected spat collected on French coasts during mortality
outbreaks in 2008. Results of the experimental trials showed that mortalities were induced after injection. Moreover,
filtered tissue homogenates induced mortalities whereas the same tissue homogenates exposed to an ultraviolet
(UV) treatment did not induce any mortality suggesting that oyster spat mortalities require the presence of a UV
sensitive agent. Furthermore, analysis of injected oyster spat revealed the detection of high amounts of OsHV-1
DNA by real-time quantitative PCR. Finally, TEM analysis demonstrated the presence of herpes virus particles. The
developed protocol allowed to maintain sources of infective virus which can be useful for the development of
further studies concerning the transmission and the development of OsHV-1 infection.
Introduction
World mollusc aquaculture is characterised by a focus on
a limited number of species including oysters being
raised at an industrial level. The oyster industry has
g r o w nt ob ev e r yi m p o r t a n tf o rm a n yr e g i o n so ft h e
world contributing substantially to social and economic
activity in the coastal zones. The yearly European oyster
production is the 126 000 tonnes, France being the lead-
ing Member State (115 000 tonnes/year) [1]. The French
oyster production is essentially based on the rearing of
the Pacific cupped oyster, Crassostrea gigas.T h i ss p e c i e s
has been introduced in France from Canada and Japan in
the early 70’s after the extinction of the Portuguese oyster
C. angulata related to irido-like virus infections [2].
However, since the late 80’s abnormal mortality events
have been reported in France among C. gigas oysters in
the field and in hatcheries/nurseries [3-5]. These
mortalities were usually sudden and severe (up to
100%), and affected essentially spat (oysters less than
one year old) and juveniles (12 to 18 month old oysters).
Mortality outbreaks took place currently during the
summer period from mid May to July concomitantly
with a rapid increase of seawater temperature (Garcia et
al., unpublished data). These recurrent mortality events
have been mainly associated to the detection of the
ostreid herpesvirus 1 (OsHV-1), the sole member of the
Malacoherpesviridae family [6-8].
The first description of a virus morphologically similar
to herpes viruses was reported by Farley et al. [9] in the
eastern oyster Crassostrea virginica.H e r p e s - l i k ev i r u s
infections have then been noticed worldwide in several
other mollusc species in association with massive mor-
tality episodes, such as in oysters [10-17], in clams
[11,18], in scallops [19] and in abalone [20-22]. Data
available in literature [4] and those collected during an
epidemiological survey conducted by the French
National Network for Surveillance and Monitoring of
Mollusc Health (Repamo) between 1997 and 2006
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OsHV-1 detection in France (Garcia et al., unpublished
data). Results of diagnostic tests indicated that OsHV-1
was detected in most of samples collected during mor-
tality outbreaks and especially in moribund oysters
(Garcia et al., unpublished data). To date, the infectivity
of OsHV-1 was univocally demonstrated towards early
stages of C. gigas through experimental trials. Experi-
mental transmission assays have demonstrated that
healthy larvae could be infected by contact with filtered
(0.22 μm) tissue homogenates prepared from infected
larvae [10,11,23,24]. So far, assays to reproduce the virus
disease in experimental conditions on oyster spat have
been inconclusive [25].
Massive mortality outbreaks in C. gigas oysters were
reported in France, Ireland and the Channel Islands in
2008 and 2009 resulting in a shortage in supplies of the
shellfish over the next years. Different hypothesis includ-
ing the implication of environmental factors, toxic algae
and/or pathogens have been explored. In this context,
oyster samples were collected from all affected locations
in France and tested in order to identify pathogens. Dif-
ferent analyses were carried out including histology, bac-
teriology, PCR for the detection of OsHV-1 [26,27],
Vibrio splendidus and V. aestuarianus [28], transmission
electron microscopy (TEM), and experimental trials.
Results of diagnostic tests indicated (Renault et al.,
unpublished data) that (i) there was no listed pathogen
involved, (ii) OsHV-1 was detected in most of samples
especially in moribund oysters, (iii) V. splendidus, V.
aestuarianus and V. harveyi were also detected and (iv)
virus particles looking like herpes viruses were observed
by TEM in moribund tested oysters.
Experimental trials were also performed in order to
reproduce mortality from naturally infected oysters col-
lected in 2008 during mortality outbreaks and to test
the hypothesis of infectious disease aetiology. In this
context, an experimental protocol was developed. This
protocol was based on (i) infectious tissue homogenates
prepared from naturally infected oysters collected in the
field during mortality outbreaks and (ii) intramuscular
injection of these tissue homogenates in healthy appear-
ing oyster spat. Mortality was daily monitored after
injection and OsHV-1 DNA systematically researched
by real time quantitative PCR. Some samples were also
subjected to TEM analysis.
Materials and methods
Oysters
Three batches of moribund Crassostrea gigas oysters
were collected on the field along the French coasts dur-
ing abnormal mortality outbreaks in 2008 (Table 1). The
first batch was composed of oysters collected at Gouville
(Normandy - Cotentin), the second of oysters collected
in the estuary of the Etel river (Brittany - Morbihan),
and the last one corresponded to oysters collected on
the site of Aulne located in the Bay of Brest (Brittany -
Finistère). These animals were checked for OsHV-1
detection and served for the preparation of tissue homo-
genates. A control tissue homogenate was prepared
from the batch of healthy appearing oysters used for
experimental assays and showing no mortality in 2008
(see below; Table 1).
Experimental infection trials were performed on
healthy appearing C. gigas spat (one year old) purchased
in November 2008 from a shellfish farm located on the
French Mediterranean coast. No mortality event has
been reported at this shellfish farm location during
2008. Oyster spat sized around 40 mm in length, with a
mean weight of 5 grams. Oysters were placed in the
Ifremer’s facilities (Laboratoire de Génétique et Patholo-
gie, La Tremblade, France) in a single tank of 200 L
containing filtered (1 μm) seawater and slowly accli-
mated to 22°C increasing the temperature of 1°C per
day. During this period, oysters were fed daily by addi-
tion of 2 liters of microalgae Skeletonema costatum
(1.5 10
3 cells/mL). Oysters did not present any mortality
or other symptom of disease at this time. At the end of
the acclimatization period and just before the beginning
of the experiment, a set of 20 individuals was assessed
by real time quantitative PCR in order to evaluate the
initial OsHV-1 DNA detection.
No ethical approval has been requested for the present
study because experimental research has been con-
ducted on Pacific oysters (invertebrates). Oysters don’t
possess a central nervous system.
Preparation of oyster tissue homogenates
Initial tissue homogenates were prepared using ten ani-
mals from each batch (Table 1). Oysters were open by
removing the superior valve. To verify that animals were
OsHV-1 infected, a small piece of mantle (25 mg) was
sampled from each individualu s e da n df r o z e na t- 2 0 ° C
before DNA extraction and OsHV-1 detection by real
time quantitative PCR. Gills and mantle of these animals
were then dissected and pooled together in a 50 mL
sterile tube. All subsequent dilutions were made using
0.22 μm filtered artificial seawater (ASW). The total
mass of tissues was weighted and 10 volumes of
0.22 μm ASW were added in the tube (9 mL of seawater
per g of tissues). Tissues were then crushed on ice using
an Ultraturax mixer (3 × 5 s). After centrifugation (1000
g, 5 min, 4°C), supernatant was placed in a new tube
and diluted by addition of 4 volumes of ASW. Finally,
the clarified tissue homogenate was filtered consecu-
tively in sterile conditions using syringe filters at 5 μm,
2 μm, 0.45 μm and 0.22 μm pore sizes (Millipore; Billerica,
USA).
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the same protocol from dying and dead animals after
intramuscular injections. Similarly, control tissue homo-
genates were also prepared using healthy oysters (oysters
from Mediterranean coast).
Filtered tissue homogenates were stocked at 4°C until
use. A volume of 200 μL of each filtered tissue homoge-
nate was sampled and stored at -20°C for further DNA
extraction and OsHV-1 DNA quantification by real time
quantitative PCR.
Experimental design: intramuscular injection of filtered
tissue homogenates
Each experimental trial (6 assays were conducted in tri-
plicates) was carried out using 8 healthy oyster spat
(Experiment 1, Figure 1) or 10 healthy oyster spat
(Experiment 2 to 6, Figure 1). Animals were first placed
out of water for 24 h at 22°C and then anesthetized dur-
ing 4 h in a solution containing 7% (w/v) magnesium
chloride (MgCl2; 50 g/L) in seawater (1 v)/distilled water
(4 v) [29]. Once a time relaxed, 100 μL of a filtered tis-
sue homogenate exposed or not to an UV treatment
were injected into the adductor muscle using a 1 mL
micro-syringe equipped with 18-g needles.
Filtered tissue homogenates in Experiment 2 were
subjected to a UV treatment adapted from Chan and
Guilbert [30]. Samples were exposed 15 mm at 10 cm of
a UV lamp (VL115-C, Vilber Lourmat, 15 W) emitting a
dose of 1.08 mW/cm² at 254 nm.
Negative controls (Experiments 1 to 6) consisted of
oysters intramuscularly injected with control tissue
homogenates prepared from healthy spat. Inoculated
oysters were then placed at 22°C in 5 L tanks supplied
in filtered (1 μm) seawater without food supply. Mor-
tality was daily monitored during a 7 day period. Dead
oysters were removed from tanks during the time
course of the experiments and a piece of mantle
(25 mg) was sampled on each dead individual. Samples
of mantle were also dissected on surviving oysters
which were sacrificed at the end of experiments. All
tissue samples were frozen at -20°C for further DNA
extraction and OsHV-1 detection by real time quanti-
tative PCR.
DNA extraction
Total DNA was extracted from tissue fragments (man-
tle) and tissues homogenates (mantle + gills) using the
QIAgen (Hilden, Germany) QIAamp tissue mini kit
combined with the use of the QIAcube automate
according to the manufacturer’s protocol.
Briefly, samples of mantle were digested overnight on
a rocking platform at 56°C by addition of 180 μLo f
ATL supplied buffer with 20 μLo fp r o t e i n a s eKp e r
25 mg of sample. When the tissue was completely lyzed,
total volume of 200 μL of lysate was transferred into a
2 mL microcentrifuge tube and DNA extraction with
QIAamp Mini spin columns was carried out using a
QIAcube automate. Final elution of DNA extracted
from mantle samples was performed with 200 μLo f
double-distilled water.
For tissue homogenates, DNA was extracted from
200 μL of samples and performed manually with a final
elution with 50 μL of double-distilled water.
DNA concentrations and DNA quality were measured
using a spectrophotometer Eppendorf (Hamburg,
Germany). Extracted DNA was stored at -20°C prior
OsHV-1 detection and quantification by real time quan-
titative PCR.
OsHV-1 DNA quantification by real time quantitative PCR
The detection and quantification of OsHV-1 DNA was
carried out using real-time PCR [26]. After dilution at
2n g / μL, 5 μL of DNA samples were added to the reac-
tion mix composed of 12.5 μL of Brillant
® SYBR Green
Master Mix reagent (Agilent; Santa Clara, USA), 2.5 μL
of both C9 forward and C10 reverse primers [31] diluted
at the concentration of 2 μm each, and 2.5 μLo fd i s -
tilled water. All amplification reactions were performed
using a Mx3000P real-time PCR thermocycler (Agilent)
with 96-microwell plates according to the following con-
ditions: 1 cycle of pre-incubation at 95°C for 10 min; 40
cycles of amplification at 95°C for 30 s, 60°C for 1 min,
and 72°C for 1 min; and a final step for melting tem-
perature curve analysis at 95°C for 1 min, 60°C for 30 s,
and 95°C for 30 s. The specificity of the PCR products
was systematically checked with the melting temperature
value calculated from the dissociation curve [32].
Table 1 Description of the four different initial tissue homogenates made from naturally OsHV-1 infected oyster spat
collected on the field in France during the abnormal mortality outbreak in 2008
Name Origin of animals Virus DNA amount OsHV-1 genotype
Homogenate 1 Normandy (Cotentin) 4.21 × 10
2 μVar
Homogenate 2 South Brittany (Morbilhan) 2.18 × 10
3 μVar
Homogenate 3 North Brittany (Bay of Brest) 2.03 × 10
2 μVar
Homogenate 4 Mediterranean sea 0 -
Virus DNA amounts of oyster tissue homogenates were quantified by real-time quantitative PCR and expressed as the number of virus DNA copies per μLo f
water. OsHV-1 genotypes of homogenates were determined by sequencing of the virus genome.
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Page 3 of 13Figure 1 Scheme of the experimental trials undertaken in the present study to reproduce virus OsHV-1 infection. Experiments 1 and 2
were carried out using tissue homogenates prepared from naturally infected oysters. Experiments 3 to 6 were performed using tissue
homogenates made from experimentally infected oysters.
Schikorski et al. Veterinary Research 2011, 42:27
http://www.veterinaryresearch.org/content/42/1/27
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carried out by comparing CT values obtained for tested
samples with the standard curve based on a ten-fold
dilution curve derived from a stock solution of OsHV-1
genomic DNA (5 × 10
6 copies/μL )e x t r a c t e df r o mp u r i -
fied virus particles [6]. Efficiency (E) and linearity (R²)
were calculated from the standard curve with MxPro
v3.0 software (Agilent), and tested for each run. All
samples were analyzed in triplicate. The results were
expressed as a log
10 of the virus DNA copy number per
ng of total DNA or per μL of control or infectious
homogenates.
Transmission electron microscopy examination
Fragments of mantle, adductor muscle and digestive
gland were collected from 3 moribund oysters after
injection of filtered tissue homogenate (Experiment 1,
Figure 1) and fixed in 2.5% (v/v) glutaraldehyde in
0.2 M cacodylate buffer (pH 7.2) for 2 h at 4°C. After
2 washes in 0.2 M cacodylate buffer (pH 7.2), samples
were post-fixed in 1% (w/v) osmium tetroxide in the
same buffer (1 h, 4°C). The samples were then washed
in 0.2 M cacodylate buffer (pH 7.2) (2 × 15 min), dehy-
drated in a graded series of ethanol (70%, 10 min;
95%, 2 × 15 min; 100%, 3 × 20 min at room tempera-
ture), cleared in propylene oxide (2 × 20 min), infiltrated
(propylene oxide/Epon resin (vol/vol), 1 h at room tem-
perature; Epon resin, 1 h at room temperature) and
embedded in Epon resin (48 h at 60°C). Ultrathin sec-
tions were cut using a Leica (Wetzlar, Germany) micro-
tome, collected on copper grids and double stained with
uranyl acetate and lead citrate using conventional tech-
niques. Examination was carried out on a JEOL JEM
1011 (Tokyo, Japan) transmission electron microscope
at 60 kV.
Sequencing of OsHV-1 genome
OsHV-1 isolates were characterized by sequencing PCR
products using primer sets targetting two regions of the
virus genome, the region IA (ORF43) that encodes a
putative apoptosis inhibitor and the region C (ORF4)
that encodes two proteins of unknown function [33].
The first primer pair used IA1/IA2 (IA1: CGC GGT
TCA TAT CCA AAG TT/IA2: AAT CCC CAT GTT
TCT TG CTG) amplified a 607 bp fragment and the
second primer pair, C2/C6 a (C2: CTC TTT ACC ATG
AAG ATA CCC ACC/C6: GTG CAC GGC TTA CCA
TTT TT) amplified a 709 bp fragment. The sequencing
reaction was carried out into a 10 μL final volume, con-
taining 1.8 μL of sequencing buffer, 0.4 μLo fB i g D y e
®
Terminator v3.1 (Applied Biosystems; Carlsbad, USA),
1.5 μL of primer Forward or Reverse at 4 μM, fresh pur-
ified PCR products and 10 μL sterile DNAse and RNAse
free water. The program consisted of an initial
denaturation of 3 min at 96°C followed by 35 cycles of
30 s at 96°C, 30 s at 50°C and 4 min at 60°C. This reac-
tion was performed using a 96-well plate. Sequencing
reactions were then purified as follows. In each sample,
60 μL of 100% ethanol were added and samples were
centrifuged at 1500 g for 30 min. The plate was inverted
to remove ethanol. Then, 60 μL 70% ethanol were
added, followed by centrifugation of the plate at 1000 g
for 10 min. The plate was then centrifuged upside down
for 30 s to remove ethanol. Finally, samples were dried
in a Speed Vac and re-suspended with 10 μL deionized
formamide. Samples were loaded in ABI PRISM
® 3130
XL-Avant Genetic Analyzer (Applied Biosystems), using
a 36 cm capillary array and POP 7 polymer. Sequences
were edited with Chromas lite 2.01 version software.
A multiple alignment was achieved by Bioedit 7.0.9
version software using the algorithm CLUSTAL W.
Sequence results were compared to the consensus
sequence OsHV-1 available on GENBANK [accession
number AY509253].
Statistical analysis
Statistical analyses were carried out using the XLSTAT-
Pro
® v7.5.3 software (Addinsoft; Paris, France). Mortality
rates after injection of the different tissue homogenates
were tested using a Khi² test. A non-parametric Kruskal-
Wallis test followed by a Dunn post-hoc comparison
test was performed to compare differences between
means of virus DNA amounts (DNA copy number)
quantified in dead or alive oyster tissues. A P-values
level of 0.05 was used in all tests to identify signicant
effects or differences.
Results
Inducing oyster mortality by tissue homogenate injection
In a first experiment (Experiment 1), four filtered tissue
homogenates (Table 1) were tested by intramuscular
injection in healthy oyster spat. Tissue homogenates 1, 2
and 3 were prepared using moribund oysters which
proved to be naturally infected by OsHV-1 collected in
Normandy (Cotentin), in South Brittany (Morbihan) and
in the Bay of Brest (Finistère), respectively (Table 1).
OsHV-1 DNA amounts quantified in filtered tissue
homogenates 1, 2 and 3 were 4.21 × 10
2, 2.18 × 10
3 and
2.03 × 10
2 DNA copies/μL, respectively. Moreover,
sequence analysis revealed the presence of OsHV-1
μVar genotype in the three tissue homogenates [33]. No
virus DNA was detected in thef i l t e r e dt i s s u eh o m o g e -
nate 4 which was prepared from a batch of healthy
oysters collected from Mediterranean coast (Table 1).
For the first experiment (Experiment 1), mortality
rates recorded in healthy oyster spat after intramuscular
injection of tissue homogenates were represented on
Figure 2. For tissue homogenate 1, the cumulative
Schikorski et al. Veterinary Research 2011, 42:27
http://www.veterinaryresearch.org/content/42/1/27
Page 5 of 13mortality rate reached 50% at day 3 post injection and
remained stable until day 6, before to reach 70% at day
7. For tissue homogenate 3, the cumulative mortality
rate reached 40% at day 3 post injection before to get
around 65% at day 5 until the end of the experiment.
Oyster spat intramuscularly injected with tissue homo-
genate 2 demonstrated a cumulative mortality rate of
25% 2 days post-injection. The mortality rate reached
gradually 90% at day 4 and stayed stable until the end of
the experiment. The mortality rates observed after injec-
tion of tissue homogenate 3 appeared significantly
higher from the fourth day of the experiment to those
observed with tissue homogenates 1 and 2. No mortality
was observed in oyster spat injected with tissue homoge-
nate 4, which constituted the negative control tissue
homogenate (Figure 2).
The quantification of OsHV-1 DNA was carried out in
dying or dead individuals collected during the time
course of the experiment (Experiment 1) and in surviv-
ing individuals collected at the end of the experiment
(Figure 3). The average virus DNA amounts were 3.67 ×
10
5,2 . 3 5×1 0
5 and 2.17 × 10
5 DNA copies/ng of total
DNA extracted from mantle in dying or dead oysters
injected with tissue homogenates 1, 2 and 3, respec-
tively. Individual virus DNA amounts ranged from
3.19 × 10
4 to 5.93 × 10
5,6 . 6 7×1 0
4 to 5.23 × 10
5,a n d
1.59 × 10
4 to 5.07 × 10
5 DNA copies/ng of total DNA
extracted from mantle for dying or dead oysters,
injected with tissue homogenates 1, 2 and 3, respec-
tively. No virus DNA was detected in surviving
individuals, except for oysters surviving after injection of
t h et i s s u eh o m o g e n a t e3w h i c hp r e s e n t e dam a x i m u m
virus DNA amount of 6.13 × 10
1 DNA copies/ng of
total DNA extracted from mantle. No virus was detected
in animals injected with the negative control tissue
homogenate (tissue homogenate 4).
Transmission electron microscopy of 3 moribund
oysters after injection of tissue homogenate 1 (Experi-
ment 1, Figure 1) revealed virus particles with morphol-
ogy that closely resembled herpes viruses in the
adductor muscle, the mantle (Figure 4,A and 4B) and
the digestive gland. These oysters were collected two
days after injection of the filtered (0.22 μm) tissue
homogenate. Intra-nuclear empty capsids, nucleocapsids
and enveloped particles were noticed (Figure 4,A and
4C). Moreover, numerous particles interpreted as Light
particles (L-particles; capsidless particles) were also
observed into perinuclear cisterna and cytoplasmic vesi-
cles of infected cells (Figure 4,C and 4D). L-particles
were spherical, ranged in size between 76 nm and
63 nm and contained homogeneous granular material of
low electron density.
Effect of UV treatment on oyster mortality induction
The effect of UV treatment on the infectivity of tissue
homogenates was investigated in a second experiment
(Experiment 2). Injection of tissue homogenates 1 and 2
induced cumulative mortality rates of 40% three days
post-injection before to reach 70% and 80% at the end
of the experiment on day 7, respectively (Figure 5). No
Figure 2 Cumulative mortality of Pacific oyster spat recorded after injection of filtered (0.22 μm) tissue homogenates made from
different batches of moribund oyster spat naturally infected by OsHV-1 and collected on the field. Tissue homogenates 1, 2, 3 were
made from moribund oyster spat collected in Normandy, South Brittany and the Bay of Brest, respectively. Homogenate 4 was made from
healthy oyster spat from Mediterranean Sea. Results are represented as the percentage of cumulative mortality (n = 8).
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sue homogenates 1 and 2 previously exposed to an UV
treatment (Figure 5).
The virus DNA quantification was determined in
dying or dead individuals collected during the time
course of the experiment (Experiment 2), (Figure 6).
The average virus DNA amounts were 2.51 × 10
5 and
3.91 × 10
5 DNA copies/ng of total DNA after injection
of tissue homogenates 1 and 2, respectively. Individual
OsHV-1 DNA amounts ranged from 7.83 × 10
3 to
6.55 × 10
5 and 1.51 × 10
1 to 1.86 × 10
5 DNA copies/ng
of total DNA extracted from mantle after injection of
tissue homogenates 1 and 2, respectively.
Virus DNA was also detected in surviving individuals
collected at the end of the experiment with values
reaching up to 1.86 × 10
5 and 4.19 × 10
5 DNA copies/
ng of total DNA after injection of tissue homogenates 1
or 2, respectively (Figure 6). Statistical analysis revealed
that the average virus DNA amounts detected in the
mantle of oyster spat were not significantly different in
dying or dead individuals after injection of tissue homo-
genates 1 and 2. No virus DNA was detected in oyster
spat surviving to the injection of tissue homogenate 1
previously exposed to UV. Only two individuals were
positive for OsHV-1 DNA detection in individuals
injected with tissue homogenate 2 previously exposed to
UV at very low levels (1.97 and 4.28 OsHV-1 DNA
copies/ng of total DNA).
Reproducing mortalities in experimental conditions
To demonstrate the reproducibility of inducing oyster
mortalities in experimental conditions by intramuscular
injection of tissue homogenates containing OsHV-1
DNA, four successive experimental transmission trials
(Experiments 3 to 6) were carried out (Figure 1). Each
experiment was carried out by injecting in the adductor
muscle of healthy oyster spat a tissue homogenate pre-
pared from dead oysters collected during the previous
experimental assay. Dying or dead oysters collected after
intramuscular injection of the initial tissue homogenate
2 were used to prepare the first tissue homogenate from
experimentally infected oysters (Figure 1). The mean
mortalities recorded during the four consecutive experi-
mental transmission trials were around 40% two days
after injection (Figure 7). Mean mortality rates increased
gradually to reach 80% at day 4 and 85% at the end of
the experiments at day 7. No statistical differences were
evidenced between mean mortality rates recorded dur-
ing these four consecutive experimental transmission
trials and the mortality rates previously reported after
the first intramuscular injection of the tissue homoge-
nate 2 (Experiments 1 and 2). Moreover, the mortality
rates reported at each monitoring point were not signifi-
cantly different between the four consecutive trials.
Average virus DNA amounts quantified in the mantle
of dying or dead individuals collected during experimen-
tal transmission assays were estimated at 1 × 10
6, 8.32 ×
10
5,5 . 3 7×1 0
5 and 4.01 × 10
5 DNA copies/ng total





Figure 3 Virus DNA detection by real time quantitative PCR in
dead or surviving oyster spat after injection of the different
filtered (0.22 μm) tissue homogenates made from moribund
oyster spat naturally infected by OsHV-1 and collected on the
field. Tissue homogenates 1, 2 and 3 were made using moribund
oyster spat collected in Normandy (A), South Brittany (B) and the
bay of Brest (C), respectively. Tissue homogenate 4 was made using
healthy oyster spat from Mediterranean Sea (D). Results are
expressed as the mean number of virus DNA copies detected per
ng of total DNA extracted from samples of mantle.
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Page 7 of 13were not significantly different between the different
trials. The quantification of OsHV-1 DNA was also car-
ried out in each different tissue homogenates used.
V i r u sD N Aa m o u n t so f2 . 5 0×1 0
6,2 . 0 1×1 0
5,3 . 0 2×
10
5 and 8.25 × 10
4 DNA copies/μL were detected in tis-
sue homogenates injected during the four experimental
transmission assays, respectively.
Discussion
Significant cumulative mortality rates (around 80%) were
observed in healthy oyster spat intramuscularly injected
with filtered (0.22 μm) tissue homogenates prepared
from naturally OsHV-1 infected oysters (Experiments 1
and 2). First mortality was reported two days after injec-
tion. As suggested by Sauvage et al., this period may
correspond to an intense replication phase leading to
irreversible cell damages resulting in mortality [34].
In addition, tissue homogenates prepared from experi-
mentally infected oyster spat induced also high mortality
rates (Experiments 3 to 6) demonstrating the reproduci-
bility of the experimental protocol. Finally, filtered tissue
homogenates exposed to UV did not induce any
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Figure 4 Transmission electron micrographs of OsHV-1 infected tissues from Pacific oyster spat. A: enveloped particles (arrows) and
L-particles (arrows head) detected in adductor muscle tissue. Scale bar = 1 μm; B: capsids (arrows) and nuclocapsids (arrows head) detected in
the nucleus of an infected cell in the mantle. Scale bar = 2 μm; C: high magnification of capsids (arrows) and nucleocapsids (arrows head)
present in the nucleus of a mantle cell from an infected oyster. Scale bar = 500 nm; D: high magnification of L-particles detected in the mantle
of an infected oyster. Scale bar = 1 μm.
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in experimental conditions was related to the presence
in oyster tissue homogenates of an infectious agent
under 200 nm in size and sensitive to UV treatment. Fil-
tration at 0.22 μm of tissue homogenates is used in
order to retain bacteria that might be present in tissues
of moribund oysters. OsHV-1 appears as an ideal candi-
date due to its size and its envelop. As OsHV-1 is an
e n v e l o p e dv i r u s ,i tm a yb ea s s u m e dt h a ti ti sf r a g i l e .
High temperature, chemicals and UV [35,36] may
destroy its lipid containing envelope. The virus envelope
is needed for herpes virus entry in target cells. However,
tissue homogenates might also contain other viruses or
substances such as bacterial toxins able to induce mor-
tality [37].
Real-time quantitative PCR analysis of intramuscularly
injected oysters revealed the presence of high amounts
of OsHV-1 DNA suggesting that active virus replication
occurred in injected oyster. Moreover, TEM examina-
tion demonstrated the presence of herpes virus particles
in mantle, adductor muscle and digestive gland of mori-
bund oysters and confirmed real time quantitative PCR
results. Virus particles demonstrated all the characteris-
tics of OsHV-1 [11,16,38]. Moreover, numerous particles
interpreted as L-particles were also detected in mori-
bund oysters. Although L-particles were not previously
reported in the existing body of literature on mollusc
herpes viruses, such particles have been already
described for vertebrate herpes viruses including herpes
simplex virus 1 and 2, and pseudorabies virus [39-41].
L-particles are capsidless particles and lack the virus
genome, but appear to contain all virus envelop and
tegument proteins. Finally, in examined samples no
virus particles morphologically related to virus families
other than herpes viruses were observed by TEM.
Four postulates for the establishment a causal rela-
tionship between a pathogen and a disease have been
first proposed by Koch in 1890 [42]. These postulates
require that (i) the microorganism must be present in
abundance in all organisms suffering of the disease, but
absent from healthy organisms; (ii) the microorganism
must be isolated from moribund organisms and culti-
vated in vitro; (iii) the cultivated microorganism should
induce the development of the disease when introduced
into a healthy organism; (iv) t h eo r g a n i s mm u s tb ei s o -
lated again from the new host organism infected and
identified as being identical to the original infectious
agent. Our results full filled at least three of the four
Henlé-Koch postulates [43]. The virus was detected in
large amounts in oysters collected in the field during
mortality outbreaks (1st postulate). Although the virus
was not cultivable in vitro at present due to the lack of
susceptible cell lines, the injection of filtered (0.22 μm)
tissue homogenates prepared using naturally OsHV-1
infected spat induced high mortality rates in healthy
oysters (3rd postulate). Finally, OsHV-1 was again
detected based on real time quantitative PCR and TEM
in injected oyster spat (4th postulate). Real time quanti-
tative PCR analyses [26] showed that high amounts of
virus DNA (approximately 1 × 10
5 DNA copies/ng of
total DNA) were detected in the mantle of dying/dead
oysters after intramuscular injection. As previously
reported [16,26,34,44], the mantle appears as a target
organ for OsHV-1 replication and may be recommended
for epidemiological studies. Moreover, virus DNA
amounts comparable to those quantified in the mantle
of dying/dead individuals were detected in some surviv-
ing oysters at the end of the experiments. Such a result
confirmed that all animals were infected after injection
of tissue homogenates. In our study, an intramuscular
route of infection was chosen to ensure that all experi-
mental oysters were contaminated by the virus at the
same time. Surviving oysters at the end of experiments
(day 7 post-injection) may represent individuals col-
lected before they died and/or be considered as less sus-
ceptible animals which developed the virus infection less
rapidly. These results suggest that the susceptibility to
the disease varies among oysters related to genetic
diversity.
In this context, OsHV-1 may interpreted as the causa-
tive agent of oyster spat mortality noticed after filtered
(0.22 μm) tissue homogenate injections. In addition to
transmitting OsHV-1 infection by intramuscular inocu-
lation, the virus can be also waterborne transmitted to
healthy oyster spat, via co-habitation of healthy oyster
spat with experimentally infected individuals [45].
Previous experimental works have been able to
strengthen a causal link particularly concerning C. gigas
larval stages. It was established that OsHV-1 induced
Figure 5 Cumulative mortality of Pacific oyster spat recorded
after injection of two different filtered (0.22 μm) tissue
homogenates exposed or not to a UV treatment. Tissue
homogenates 1 and 2 were made from moribund oyster spat
collected in Normandy and South Brittany, respectively. Results are
represented as the percentage of cumulative mortality (n = 10).
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duce the virus infection in oyster spat have been incon-
clusive [25]. A first experimental data set indicated that
OsHV-1 could be transmitted to healthy C. gigas spat
through cohabitation with experimentally infected larvae
when spat were kept in stressful conditions (Renault,
unpublished data).
The intra-muscular injection of tissue homogenates
prepared from infected oysters was used successfully in
the present study. The capacity to reproduce the virus
disease in the present study may be due to (i) the route
of contamination (ii) the use of fresh infected oysters as
the virus source and/or (iii) the use of a particular virus
genotype (OsHV-1 μVar) presenting a high virulence.
Although two ostreid herpesvirus 1 genotypes were pre-
viously characterized in France (OsHV-1 reference
genotype and OsHV-1 var genotype) [11], the presence
of a third genotype, termed OsHV-1 μVar, was reported
in France in 2008 and 2009 in association with abnor-
mal mortality outbreaks among French C. gigas [33].
Both OsHV-1 genotypes (reference and μVar) were
detected in association with mortality outbreaks in 2008.
Otherwise, the data collected in 2009 during French
oyster mortality outbreaks demonstrated only the geno-
type OsHV-1 μVar detection. These results raise ques-
tions about the emergence and the virulence of OsHV-1
μVar genotype. Moreover, L-particles were detected in
moribund oysters and may be related to increased viru-
lence. Although the exact role of herpes virus L-particles
remains to be determined, some authors suggested that
these particles supply functions which can boost suc-
cessful initiation of the infectious process under adverse
Homogenate 2 not exposed to UV  Homogenate 2 exposed to UV  B 
Homogenate 1 not exposed to UV  Homogenate 1 exposed to UV  A 
Figure 6 Virus DNA detection by real time quantitative PCR in dead or surviving oyster spat after injection of two different filtered
(0.22 μm) tissue homogenates exposed or not to a UV-treatment. Tissue homogenates 1 and 2 were made with moribund oyster spat
collected in Normandy (A) and South Brittany (B), respectively. Results are expressed as the mean number of virus DNA copies detected per ng
of total DNA extracted from samples of mantle.
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vivo in enhancing reactivation from latency [39,48].
However, some experimental trials performed in 2008
with the reference like genotype, based on two ORF
sequences characterization, showed that mortality could
also be induced (data not shown). Further work is
needed to fully investigate possible infectivity and viru-
lence differences between OsHV-1 genotypes.
However, the demonstration of a causal link between
a pathogen and mortality outbreaks in the field is not
only based on the possibility of reproducing the disease
experimentally, but should take into account the idea
that the cause of mortality outbreaks can also be a com-
bination of factors. A causal link between OsHV-1 infec-
tions and oyster spat mortalities has been suggested in
different epidemiological studies on summer oyster mor-
talities worldwide [25,49,50]. In France, this causal link
has been highlighted through an epidemiological moni-
toring over several years conducted by the National Net-
work for Surveillance and Monitoring of Mollusc Health
(unpublished data), which is based on a passive surveil-
lance and laid down on oyster mortality declarations by
shellfish farmers.
Although the absence of bivalve cell lines does not
allow to cultivate the virus in vitro [25], the protocol
developed in the present study allows to produce tissue
homogenates containing infective virus particles. Preli-
minary assays have showed that tissue homogenates
could be stocked at 4°C for one month keeping infectiv-
ity. During this time of storage, real time quantitative
PCR analyses showed that the virus DNA amounts did
not vary (data not shown). However, real time quantita-
tive PCR does not allow the quantification of infective
virus particles, which are necessary to initiate the virus
infection in host-cells [51]. Nevertheless, our protocol
may allow to maintain sources of infective virus particles
through repeated experimental infections of healthy
Figure 7 Reproducibility of mortality on Pacific oyster spat
after injection of different infectious OsHV-1 homogenates
made from experimentally infected animals. The dash line
represent the mortality recorded after injection of the initial
homogenate 2, which is made from naturally infected oyster spat
collected on the field (South Brittany). The dotted lines corresponds
to mortalities recorded in five consecutive transmission assays
conducted using five different homogenates made from oyster spat
dead previously in experimental conditions. The mean mortality is
indicated by the solid line. Results are expressed as the percentage
of cumulative mortality (n = 10). Standard deviation is represented
by error bars.
Figure 8 Average virus DNA amounts estimated in the mantle of oyster spat dead in five consecutive transmission assays conducted
using five different homogenates made from oyster spat dead previously in experimental conditions. Stars represent virus DNA amounts
of the different homogenates used in these consecutive transmission assays. Virus DNA amounts were quantified by real-time quantitative PCR.
Standard deviation is represented by error bars.
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Page 11 of 13oyster spat. However, care must be taken that the virus
does not loss its infectivity through successive in vivo
passages.
The present study described an experimental protocol
allowing to prepare tissue homogenates containing
infective OsHV-1 particles. Results showed that it is
possible to maintain sources of infective virus and con-
tributed to the set up of a reproducible model for study-
ing the infectivity of OsHV-1 in C. gigas oysters in
experimental conditions, which can be useful to obtain
information including potential mechanisms of trans-
mission, entry routes, virus stability and virus-host
interactions.
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